Flow cytometry reveals PD-L1 + CD68 + macrophages are elevated in non-small cell lung cancer patients, indicating their clinical significance.
Purpose: To explore the roles of PD-L1 + (programmed death-1-ligand 1) CD68 + macrophages in peripheral blood mononuclear cells (PBMCs) of non-small cell lung cancer (NSCLC) by flow cytometry (FCM). Materials and methods: 60 squamous cell carcinoma patients, 60 adenocarcinoma patients and 60 healthy controls were recruited in the study. PD-L1 + CD68 + macrophages were isolated from PBMCs of the 180 persons with FCM. Results: Squamous cell carcinoma and adenocarcinoma group had higher PD-L1 + CD68 + macrophages expression compared to healthy controls ( P <0.001 and P =0.013 respectively), and PD-L1 + CD68 + macrophages from squamous cell carcinoma were higher than that from adenocarcinoma group [(19.03±12.28)% vs (14.21±11.88)%, P = 0.031)]. Conclusions: PD-L1 + CD68 + macrophages in PBMCs have marked relationship with squamous cell carcinoma and adenocarcinoma, especially can produce profound effect on squamous cell carcinoma.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: